CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Jan. 01, 2022
Current assets:
Cash and cash equivalents	$ 19,217	$ 30,490
Patient accounts receivable	221,237	218,917
Receivables under insured programs	4,395	6,373
Prepaid expenses	15,089	14,233
Other current assets	9,813	9,202
Total current assets	269,751	279,215
Property and equipment, net	22,752	31,374
Operating lease right of use assets	54,601	51,992
Goodwill	1,159,688	1,835,580
Intangible assets, net	95,863	102,851
Receivables under insured programs	22,865	25,530
Other long-term assets	86,240	7,829
Total assets	1,711,760	2,334,371
Current liabilities:
Accounts payable and other accrued liabilities	44,624	52,624
Accrued payroll and employee benefits	43,836	54,565
Current portion of insurance reserves - insured programs	4,395	6,373
Current portion of insurance reserves	27,531	13,466
Securitization obligations	140,000	120,000
Current portion of long-term obligations	9,200	8,600
Current portion of operating lease liabilities	13,070	13,534
Current portion of deferred payroll taxes		25,523
Other current liabilities	43,841	50,146
Total current liabilities	326,497	344,831
Long-term obligations, less current portion	1,281,082	1,226,517
Long-term insurance reserves - insured programs	22,865	25,530
Long-term insurance reserves	35,470	35,122
Operating lease liabilities, less current portion	45,818	44,682
Deferred income taxes	3,844	3,046
Other long-term liabilities	359	16,692
Total liabilities	1,715,935	1,696,420
Commitments and contingencies (Note 14)
Deferred restricted stock units	2,135	2,135
Stockholders' (deficit) equity:
Preferred stock, $0.01 par value as of December 31, 2022 and January 1, 2022, 5,000,000 shares authorized; none issued or outstanding
Common stock, $0.01 par value, 1,000,000,000 shares authorized; 188,859,165 and 184,732,268 issued and outstanding, respectively	1,888	1,847
Additional paid-in capital	1,228,512	1,208,645
Accumulated deficit	(1,236,710)	(574,676)
Total stockholders' (deficit) equity	(6,310)	635,816
Total liabilities, deferred restricted stock units, and stockholders' (deficit) equity	$ 1,711,760	$ 2,334,371